InSilico Medicine has raised $10 million from six investors, according to a filing with the Securities and Exchange Commission. InSilico collects and analyzes genetic codes to make drug discoveries for aging and age-related diseases. The company uses advances in molecular biology and big data analysis with computer modeling and simulation. The bioinformatics company has reported revenue of less than $1 million. The company is located at the Emerging Technology Centers at the Johns Hopkins University…
from http://www.bizjournals.com/baltimore/news/2017/02/23/baltimores-insilico-medicine-raises-10m.html?ana=RSS%26s=article_search
via http://baltimorecheckbook.tumblr.com/post/157612283172
No comments:
Post a Comment